Jim Simons Durect Corp Transaction History

Renaissance Technologies LLC

$63.1 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.43 - $5.9 $44,465 - $610,107	103,408 Added 3.09%	3,447,243 $1.99 Million
Q2 2022 Aug 12, 2022	SELL	$0.38 - $0.64 $59,448 - $100,123	-156,443 Reduced 4.47%	3,343,835 $1.6 Million
Q1 2022 May 13, 2022	BUY	$0.55 - $0.98 $323,866 - $577,071	588,848 Added 20.23%	3,500,278 $2.35 Million
Q4 2021 Feb 11, 2022	SELL	$0.9 - $1.31 $67,050 - $97,595	-74,500 Reduced 2.5%	2,911,430 $2.87 Million
Q3 2021 Nov 12, 2021	SELL	$1.21 - $1.61 $221,188 - $294,308	-182,800 Reduced 5.77%	2,985,930 $3.82 Million
Q2 2021 Aug 13, 2021	SELL	$1.6 - $2.02 $1.17 Million - $1.48 Million	-733,166 Reduced 18.79%	3,168,730 $5.17 Million
Q1 2021 May 13, 2021	SELL	$1.86 - $2.87 $1.63 Million - $2.51 Million	-875,034 Reduced 18.32%	3,901,896 $7.73 Million
Q4 2020 Feb 10, 2021	SELL	$1.65 - $2.43 $871,860 - $1.28 Million	-528,400 Reduced 9.96%	4,776,930 $9.89 Million
Q3 2020 Nov 13, 2020	SELL	$1.6 - $2.35 $1.09 Million - $1.61 Million	-684,367 Reduced 11.43%	5,305,330 $9.07 Million
Q2 2020 Aug 13, 2020	BUY	$1.33 - $2.76 $1.04 Million - $2.16 Million	781,485 Added 15.0%	5,989,697 $13.9 Million
Q1 2020 May 14, 2020	BUY	$0.97 - $2.85 $959,330 - $2.82 Million	989,000 Added 23.44%	5,208,212 $8.07 Million
Q4 2019 Feb 13, 2020	BUY	$1.69 - $3.8 $350,997 - $789,225	207,691 Added 5.18%	4,219,212 $16 Million
Q3 2019 Nov 13, 2019	BUY	$0.61 - $2.21 $490,213 - $1.78 Million	803,629 Added 25.05%	4,011,521 $7.38 Million
Q2 2019 Aug 12, 2019	BUY	$0.51 - $0.86 $82,518 - $139,148	161,800 Added 5.31%	3,207,892 $2.09 Million
Q1 2019 May 14, 2019	SELL	$0.51 - $0.82 $149,328 - $240,096	-292,800 Reduced 8.77%	3,046,092 $1.91 Million
Q4 2018 Feb 13, 2019	BUY	$0.48 - $1.1 $1.6 Million - $3.67 Million	3,338,892 New	3,338,892 $1.61 Million

Others Institutions Holding DRRX

# of Institutions

Shares Held

593K

Call Options Held

Put Options Held

View Full List

About DURECT CORP

Ticker DRRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 227,794,000
Market Cap $171M
Description
DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogeno...

More about DRRX

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account